Background {#Sec1}
==========

Refractive errors, such as myopia and astigmatism, are the main cause of visual impairment throughout the world. A European adult population-based study found that myopia was in 35.1% of the participants and astigmatism \> 0.5 cylinder diopter (D) was in 32.3% \[[@CR1]\]. A prevalence and characteristic of corneal astigmatism (CA) in congenital cataract patients study reported that 39.25% of subjects had CA values \> 2 D \[[@CR2]\]. Another study found that 22% had CA ≥ 1.5D or higher \[[@CR3]\].

Surgical correction of spherical and cylindrical refractive errors has led to a decrease in complications as the improvement of recent technology. Accurate correction especially astigmatism is crucial to achieve better refractive outcomes. However, treatment of astigmatism is still a challenge. Transepithelial photorefractive keratectomy (TransPRK) is popularly chosen for its flapless feature and all-in-one step procedure. Several studies have evaluated the refractive and visual outcomes after TransPRK \[[@CR4]--[@CR7]\]. As for the correction of astigmatism, refractive surgeons are concerned more on the difference between small-incision lenticule extraction (SMILE), femtosecond lenticule extraction (FLEx) and wavefront-guided LASIK \[[@CR8]--[@CR11]\]. However, very few studies have focused on the efficacy of correcting astigmatism by TransPRK, especially in the vector method \[[@CR12], [@CR13]\].

The aim of this study was to evaluate the results of TransPRK in the correction of low to moderate myopic astigmatism by vector method.

Methods {#Sec2}
=======

Patient population and study design {#Sec3}
-----------------------------------

The retrospective study comprises 47 eyes of 36 patients with myopia (− 1.50 to − 5.75D) and astigmatism (− 0.75 to − 2.25D) \[[@CR14]\] who received TransPRK between October 2016 and January 2017 at the department of ophthalmology of Peking University. The demographic data for the patients were in Table [1](#Tab1){ref-type="table"}. All patients were provided written informed consent. The study protocol was in accordance with the Declaration of Helsinki and institutional review board.Table 1Demographic Data for the Cohort of EyesParameterMean ± SDAge RangeAge (y)30.69 ± 4.8519--38Gender Male (n)33.60 ± 3.57 (10)26--37 Female (n)29.58 ± 4.86 (26)19--38*SD* standard deviation, *SE* spherical equivalent refraction

All enrolled patients underwent a complete ophthalmic examination and had no ocular diseases except myopic astigmatism. Preoperative examinations included slit-lamp biomicroscopy, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography (Optikon SpA, Rome, Italy), pentacam scheimpflug topography (Oculus, Wetzlar, Germany), manifest refraction, ultrasound pachymetry and dilated funduscopy examination. Patients with CDVA under 20/20, suspicion of keratoconus and thin cornea thickness were excluded.

Surgery {#Sec4}
-------

The surgery was performed by a single surgeon using the SCHWIND Amaris 500E excimer laser platform (SCHWIND eye-tech-solutions GmbH, Kleinostheim, Germany). Ablations were based on aberration-free algorithms calculated using ORK-CAM software. The ablation profile targets epithelial thickness as 55 μm centrally and 65 μm peripherally according to the population model statistics \[[@CR6]\]. Before ablation, all patients' examinations were tested by the statistic cyclotorsion control (SCC) and dynamic cyclotorsion control (DCC) was used through the surgery. After ablation, the corneal stromal was irrigated with a cool balanced salt solution and a soft bandage contact lens was applied.

After surgery, the patients were treated with topical 0.5% levofloxacin (Cravit; Santen, Inc) eye drops four times a day for one week, 0.1% fluorometholone (Allergan, Inc) eye drops four to six times daily (tapered over 12 weeks) and preservative-free artificial tears four times daily for at least 6 months. The contact lens were removed once the epithelial closure was completed.

Main outcome measures and vector method {#Sec5}
---------------------------------------

The main outcomes include UDVA, CDVA, manifest refractive cylinder and sphere preoperatively and 6 months postoperatively.

Vector analysis of corneal astigmatism is based on the definitions and formulas given by Eydelman MB \[[@CR15]\]. The vector quantities and data used in the astigmatic analysis are shown in Fig. [1](#Fig1){ref-type="fig"} and defined as below:Fig. 1Basic astigmatic vector quantities and relationships. EA: Error of angle; EV: Error vector; EM: Error of magnitude; IRC: Intended refractive correction; SIRC: Surgically induced refractive correction

The intended refractive correction (IRC) vector: the vector difference between the preoperative astigmatic correction vector and the target postoperative cylinder vector. If the target refractive state is emmetropia, the IRC vector is equal to the preoperative astigmatic correction.

The surgical induced refractive correction (SIRC) vector: the vector difference between the preoperative and postoperative astigmatic correction vectors. SIRC is the achieved correction.

The error vector (EV): the vector difference between the IRC and SIRC (IRC-SIRC), when the refractive target is emmetropia, the EV is equal to the postoperative astigmatic correction vector.

The error of magnitude (EM): the arithmetic difference of the magnitudes between SIRC and IRC ( \| IRC \| - \| SIRC \| ).

The error of angle (EA): the angular difference between the achieved treatment and the intended treatment.

The correction ratio (CR): the ratio of the achieved correction magnitude to the required correction ( \| SIRC \| / \| IRC \| ). If the ratio = 1, it is ideal. If \> 1, it means excessive application of the treatment. If \< 1, it means under correction.

Statistical analysis {#Sec6}
--------------------

Clinical data were analyzed using SPSS 20.0. Descriptive analysis with SDs for means was performed. The distribution of the data was normality, the paired Student's *t*--test was used to analyze differences between preoperative and postoperative outcomes. Pearson correlation coefficient was used to analyze the correlation between the absolute EM and the intended cylinder correction. The relationship between the attempted refractive correction and achieved refractive correction was analyzed by linear regression analysis. A *p*-value \< 0.05 was considered statistically significant.

Result {#Sec7}
======

This study included 47 eyes of 36 patients treated by TransPRK. The mean patient age was 30.69 ± 4.85 years (range: 19 to 38 years). The preoperative and postoperative visual acuity (including UDAV and CDVA) and refractive outcomes such as sphere, cylinder, and spherical equivalent were summarized in Table [2](#Tab2){ref-type="table"}. Significant improvement was observed between preoperative and 6 months postoperatively (*p* \< 0.01).Table 2Summary statistics of refractive and visual outcomesPreop6 monthsMean ± SD\
(range) \[median\]Mean ± SD\
(range) \[median\]*P*-valueSphere(D)− 3.87 ± 1.15\
(−5.75 to − 1.50) \[− 4.00\]0.35 ± 0.46\
(− 0.50 to 1.25) \[0.25\]\< 0.01Cylinder(D)− 1.11 ± 0.40\
(− 2.25 to − 0.75) \[− 1.00\]− 0.33 ± 0.25\
(− 1.25 to 0.00) \[− 0.25\]\< 0.01MSE(D)−4.30 ± 1.27\
(− 6.38 to − 0.88) \[− 4.63\]0.18 ± 0.46\
(− 0.63 to 1.13) \[0.13\]\< 0.01CDVA(LogMAR)− 0.10 ± 0.07\
(− 0.20 to 0.00) \[− 0.10\]− 0.14 ± 0.07\
(− 0.20 to 0.00) \[− 0.10\]\< 0.01UDVA(LogMAR)0.93 ± 0.28\
(0.20 to 1.50) \[1.00\]− 0.10 ± 0.07\
(− 0.20 to 0.00) \[− 0.10\]\< 0.01*MSE* manifest spherical equivalent; *CDVA* corrected distance visual acuity; *UDVA* uncorrected distance visual acuity

Safety and efficacy {#Sec8}
-------------------

At 6 months postoperatively, all of the eyes achieved the UCDV of 20/20 or better visual acuity. No patient lost two or more lines of CDVA. Figure [2](#Fig2){ref-type="fig"} shows the preoperative CDVA against postoperative UDVA and there was no significant difference between the two variables (*P* = 0.855). The changes in CDVA between preoperative and 6 months postoperative were shown in Fig. [2](#Fig2){ref-type="fig"}. 53.2% (25 eyes) of eyes unchanged; 34% of eyes (16 eyes) gain one line, 6.4% of eyes (3 eyes) gain two lines and 6.4% (3 eyes) of eyes lose one line.Fig. 2Comparison of preoperative corrected distance visual acuity (CDVA) and postoperative uncorrected distance visual acuity (UDVA) (**a**). Change in snellen lines of CDVA at 6 months postoperatively (**b**)

Refractive outcomes {#Sec9}
-------------------

The preoperative and postoperative astigmatic refraction was shown in Fig. [3](#Fig3){ref-type="fig"}. 63.8% of the eyes with residual refractive cylinder ≤0.25D. Summaries of the refractive status were in Table [3](#Tab3){ref-type="table"}. The percentage of eyes with residual refractive cylinder ≤0.50D and ≤ 1.0D was in 93.6% (44 eyes) and 97.9% (46 eyes) respectively.Fig. 3Levels of astigmatism before (**a**) and after (**b**) transepithelial photorefractive keratectomyTable 3Summary of residual refractionResidual magnitudePercentage%(eyes)0D ≤  \| Sphere\| ≤ 0.5D72.3% (34)0.5D \<  \| Sphere\| ≤ 1.0D21.3% (10) \| Sphere\|\> 1.0D6.4% (3)0D \< Cyl ≤ 0.5D93.6% (44)0.5D \< Cyl ≤ 1D4.3% (2)Cyl \> 1D2.1% (1)0D ≤  \| SE \|  ≤ 0.5D68.1% (32)0.5D \<  \| SE\| ≤ 1.0D27.7% (13) \| SE\| \> 1.0D4.2% (2)*D* diopter; *Cyl* cylinder; *SE* spherical equivalent

The linear regression of the scattergram was shown in Fig. [4](#Fig4){ref-type="fig"}. The achieved versus attempted spherical equivalent correction has a slop of 0.89 and the achieved versus attempted astigmatism correction has a slop of 1.09.Fig. 4Achieved versus attempted spherical equivalent corrections 6 months postoperatively (**a**). Achieved versus attempted astigmatism corrections 6 months postoperatively (**b**). The red solid line indicates the outcome of linear regression analysis, the area between two dotted lines mean within ±0.50D

Vector analysis {#Sec10}
---------------

Figure [5](#Fig5){ref-type="fig"} shows the scattergram of cylinder preoperatively and the error of angle postoperatively. At 6 months, 51.1% of eyes with error of angle ≤5°and 80.9% of eyes ≤10°. No eye more than 20°.Fig. 5Scatter diagram of Error Angle (EA) for 47 eyes (A). Summary of the EA between the achieved treatment and the intendent treatment

Summarizes of all vector parameters were in Table [4](#Tab4){ref-type="table"}. The correction ratio for cylinder was 1.03 ± 0.3. The mean error of angle (EA) was 0.44 ± 7.42°. The error of magnitude (EM) was − 0.04 ± 0.36D.Table 4Vector analysis of changes in refractive cylinderVector parameterEyes (*n* = 47)\
Mean (SD)RangeIRC (D)1.11 (0.40)0.75--2.25SIRC (D)1.15 (0.57)0.27--3.45ER0.30 (0.19)0.00--0.667CR1.03 (0.3)0.36--1.59EM (D)−0.04 (0.36)−1.20-0.536EA (°)0.44 (7.42)−15.00-19.13*IRC* intended refractive correction; *SIRC* surgically induced refractive correction; *ER* error ratio; *CR* correction ratio; *EM* error of magnitude; *EA* error of angle

Discussion {#Sec11}
==========

The evaluation of the myopic correction is significant in the clinic, especially in refractive surgery. TransPRK is recommended as one of the most advanced techniques for its flapless. Several previous studies have evaluated the safety, efficacy and predictability of TransPRK \[[@CR4], [@CR5], [@CR13], [@CR16]\]. All of the eyes had postoperative UDVA 20/20 or better. 63.8% of the eyes with residual refractive cylinder ≤0.25D, and 93.6% of the eyes≤0.50D. 80.9% of eyes with EA ≤ 5°. One study found that 70.4% of eyes were within ±0.25D and 87.0% of eyes were within ±0.50D of the attempted cylindrical correction at 3 months followed SMILE surgery \[[@CR11]\]. In addition, another study achieved 79.1% of eyes within ±0.50D of intended correction of refractive cylinder \[[@CR17]\]. The results of this study indicate that TransPRK in myopic eyes with low to moderate cylinder is safe, effective and predictable.

Other refractive surgeries had been analyzed in the correction of myopic astigmatism. It is difficult to compare because of the different degrees of refractive cylinder. Studies summarized in Table [5](#Tab5){ref-type="table"} \[[@CR5], [@CR8], [@CR11], [@CR12], [@CR17]--[@CR19]\] showed that we achieved favorable outcomes in comparison to the literature review. Adib et al. \[[@CR5]\] reported that 97.26% of the eyes within ±0.50D 18 months later after the surgery of TransPRK for the correction of astigmatism. Similarly, Stojanovic et al. \[[@CR12]\] achieved 79.1% of eyes within ±0.50D 12 months later after TransPRK. Zhang J et al. \[[@CR17]\] found that 95.92% of eyes within ±0.50D followed SMILE surgery.Table 5Literature studies of myopic astigmatic correctionAuthor (year)TechniqueEyes (n)Follow-up (months)Preoperative cylinder Mean ± SD (range)Postoperative cylinder Mean ± SD (range)Within 0.50D (%)Schallhorn \[[@CR17]\] (2015)W-LASIK6113−2.76 ± 0.81 (− 2.00 to −6.00)−0.37 ± 0.38 (− 2.00 to 0.00)79.10%Stojanovic \[[@CR12]\] (2013)TransPRK11712−0.77 ± 0.65 (−4.50 to 0.00)/94.00%Adib \[[@CR5]\] (2016)TransPRK14618−1.19 ± 0.99−0.29 ± 0.2197.26%Zhang J \[[@CR18]\] (2015)SMILE9812−0.90 ± 0.68 (− 0.25 to − 2.75)−0.20 ± 0.2795.92%AI-Zeraid \[[@CR19]\] (2016)W-LASIK236−3.22 ± 0.59 (− 2.50 to − 4.50)−0.72 ± 0.4639%Ali-MA \[[@CR8]\] (2014)FLEx586− 0.97 ± 0.54 (− 0.5 to − 2.75)−0.26 ± 0.37 (− 1.00 to 0.00)86%Chan \[[@CR11]\] (2015)SMILE543−1.08 ± 0.71−0.243 ± 0.31687%Current studyTransPRK476−1.11 ± 0.40 (−0.75 to − 2.25)− 0.33 ± 0.25 (− 1.25 to 0.00)93.6%*W-LASIK* wavefront-guided Laser in situ keratomileusis; *TransPRK* transepithelial photorefractive keratectomy; *SMIL* small-incision lenticule extraction; *FLEx* femtosecond lenticule extraction

Previous studies have attempted to evaluate the refractive outcomes by the spherical equivalent (SE). It is less precise because astigmatism includes both magnitude and axis direction. For this reason, vector analysis could describe the astigmatism correctly. Very few refractive surgery results such as small-incision lenticule extraction (SMILE), femtosecond lenticule extraction (FLEx) and LASIK had been analyzed in the vector method \[[@CR7], [@CR9], [@CR11], [@CR18], [@CR20]\]. The aim of this study is to investigate the correction of low to moderate myopic astigmatism following TransPRK in vector method, which has not been reported until now.

The vector analysis of refractive cylinder showed slight overcorrection with the correction ratio (CR, ratio of the achieved correction magnitude to the required correction) of 1.03 at 6 months postoperatively. + 9% overcorrection was observed in the linear regression of the attempted astigmatism refraction. The error of angle (EA) was anticlockwise and minimal (0.44°). Compare to other studies that use vector analysis of cylinder correction, Schallhorn et al. \[[@CR7]\] found slight under correction of the refractive cylinder and a mean EA of − 0.45°following wavefront-guided LASIK in the treatment of moderate-to-high astigmatism. Katz et al. \[[@CR21]\] achieved a similar CA of 1.06 to our study, and the EA of 3.60°in eyes with preoperative refractive cylinder greater than 3.00D. Chan et al. \[[@CR11]\] found EA of − 0.85°and 2.09°in SMILE and femtosecond-assisted LASIK respectively in the correction of low to moderate myopic astigmatism. In this study, the error ratio of cylinder correction is 0.30, which is slightly higher than 0.13 reported by Schallhorn et al. \[[@CR7]\]. These results indicate that TransPRK could achieve comparable results in the correction of cylinder by comparing with other surgeries. Statistic cyclotorsion control (SCC) and dynamic cyclotorsion control (DCC) may play an important role in the correction of cylinder.

The alignment is important for the refractive cylinder correction. Misalignment could result in both higher order aberrations (HOAs) and corrective performance \[[@CR18], [@CR22]\]. In our study, 80.9% of eyes within the error of angle (EA) ≤10°, and 95.7% within ≤15°. One study found 68.4% of eyes had EA ≤10°in a group of patients with preoperative refractive cylinder of − 0.90 ± 0.68D followed SMILE surgery \[[@CR18]\]. Another study found 98.4% with EA within 10°after wavefront-guided LASIK \[[@CR7]\]. Although eye-tracking was used for every patient, the astigmatism axis could be misaligned by many factors. The cyclotorsional movements of the eyes from upright to supine position, the shift of the pupil center and the large angle kappa occurred. In addition, the epithelial thickness (55 μm centrally and 65 μm periphery) estimated by the statistic of common people may lead to deep or shallow ablation of the corneal tissue. So, precise positioning center and epithelial mapping for every patient would be of great help for the precise correction of refractive cylinder.

In conclusion, the outcomes of this study suggest that TransPRK surgery is safe, effective and predictive in the treatment of low to moderate astigmatism. Based on the findings of our study, the absolute astigmatic error of magnitude was significantly correlated with the intended cylinder correction. Further investigation should be conducted to assess the treatment for correcting higher cylinder.

Conclusions {#Sec12}
===========

TransPRK surgery is safe, effective and predictable in the correction of low to moderate astigmatism.
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